Search Results - "Costa Jr, J. Ribamar"

Intracoronary Ultrasound Assessment Late After the Arterial Switch Operation for Transposition of the Great Arteries by Pedra, Simone R.F.F., Pedra, Carlos A.C., Abizaid, Alexandre A., Braga, Sérgio L.N., Staico, Rodolfo, Arrieta, Raul, Costa, J. Ribamar, Vaz, Vinicius D., Fontes, Valmir F., Sousa, J. Eduardo R.

“…This research was undertaken to assess the status of the coronary wall morphology late after the arterial switch operation (ASO) for transposition of the great…”
Get full text

Optical Coherence Tomography Versus Intravascular Ultrasound and Angiography to Guide Percutaneous Coronary Interventions: The iSIGHT Randomized Trial by Chamié, Daniel, Costa, J. Ribamar, Damiani, Lucas P., Siqueira, Dimytri, Braga, Sérgio, Costa, Ricardo, Seligman, Henry, Brito, Freddy, Barreto, Guilherme, Staico, Rodolfo, Feres, Fausto, Petraco, Ricardo, Abizaid, Alexandre

“…[Figure: see text]…”
Get full text

The unmet needs: How future technologies will address current limitations of bioresorbable scaffold technology by Abizaid, Alexandre, Ribamar Costa Jr, J.

“…First‐generation bioresorbable scaffolds (BRS), represented by the three marked‐approved devices (Absorb BVS 1.1, DESolve NX, and DREAMS) have demonstrated, in…”
Get full text

Very Long Term Follow-Up After Percutaneous Balloon Mitral Valvuloplasty by Meneguz-Moreno, Rafael A., Costa, J. Ribamar, Gomes, Nisia L., Braga, Sergio L.N., Ramos, Auristela I.O., Meneghelo, Zilda, Maldonado, Mercedes, Ferreira-Neto, Alfredo N., Franca, J. Italo D., Siqueira, Dimytri, Esteves, Cesar, Sousa, Amanda, Sousa, J. Eduardo, Abizaid, Alexandre

“…The aim of this study was to assess very long term outcomes after successful percutaneous balloon mitral valvuloplasty (PBMV). PBMV remains the preferred…”
Get full text

Serial Assessment of Coronary Artery Healing of a Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months by Optical Coherence Tomography (OCT)-The REPAIR Trial by Silva, Guilherme Barreto Gameiro, Meneguz-Moreno, Rafael A, Costa, Ricardo, Chamié, Daniel, Dangas, George, Manica, André, Arruda, Jose Airton, Sousa, Amanda G M R, Feres, Fausto, Costa, Jr, J Ribamar

“…Although first-generation drug-eluting stent (DES) devices have effectively achieved their main goal of reducing restenosis, their safety has been limited by…”
Get more information

Long-term clinical outcomes of the Drug-Eluting Stents in the Real World (DESIRE) Registry by Sousa, Amanda, Costa, Jr, J Ribamar, Moreira, Adriana C, Cano, Manuel, Maldonado, Galo, Costa, Ricardo A, Pavanello, Ricardo, Romano, Edson R, Campos, Cantidio, Haddad, Nagib, Abizaid, Alexandre, Feres, Fausto, Mattos, Luiz Alberto, Staico, Rodolfo, Sousa, J Eduardo

“…Recently, cardiologists have treated more complex patients and lesions with drug-eluting stents (DES). However, long-term efficacy and safety of the off-label…”
Get more information

Bioresorbable Coronary Scaffolds: Deployment Tips and Tricks and the Future of the Technology by Costa, Jr, J Ribamar, Abizaid, Alexandre

“…Bioresorbable scaffolds (BRS) were developed as an alternative to drug-eluting stents (DES) to facilitate vessel restoration and reduce the risk of future…”
Get full text

1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial by Costa, Jr, J Ribamar, Abizaid, Alexandre, Costa, Ricardo, Feres, Fausto, Tanajura, Luiz Fernando, Abizaid, Andréa, Maldonado, Galo, Staico, Rodolfo, Siqueira, Dimytri, Sousa, Amanda G M R, Bonan, Raoul, Sousa, J Eduardo

“…We sought to assess the safety and efficacy of the novel VESTAsync-eluting stent (MIV Therapeutics, Atlanta, Georgia) combining a stainless steel platform with…”
Get full text

Clinical, angiographic, and intravascular ultrasound results of the VestSaync II trial by Costa Jr, J. Ribamar, Oliveira, Breno A., Abizaid, Alexandre, Costa, Ricardo, Perin, Marco, Abizaid, Andréa, Chamié, Daniel, Fernando Tanajura, Luiz, Sousa, Amanda, Sousa, J. Eduardo M.R.

“…Aim We sought to assess the long term efficacy of the novel VESTAsync™ Eluting Stent (VES) combining a Cro‐Co platform with a nanothin‐microporous…”
Get full text

Thrombus aspiration in STEMI patients: an updated systematic review and meta-analysis by Meneguz-Moreno, Rafael A, Costa, Jr, J Ribamar, Oki, Fabio H, Costa, Ricardo A, Abizaid, Alexandre

“…Clinical efficacy and safety of adjunctive thrombus aspiration (TA) in patients with ST-segment elevation myocardial infarction (STEMI) during percutaneous…”
Get more information

Rationale and design of the MGuard for acute ST elevation reperfusion MASTER trial by Costa Jr, J. Ribamar, Abizaid, Alexandre, Dudek, Dariusz, Silber, Sigmund, Leon, Martin B., Stone, Gregg W.

“…Background Primary percutaneous coronary intervention (PCI) improves survival compared with thrombolytic therapy in ST‐segment elevation myocardial infarction…”
Get full text

Incidence and Predictors of Very Late (≥4 Years) Major Cardiac Adverse Events in the DESIRE (Drug-Eluting Stents in the Real World)-Late Registry by Costa, J. Ribamar, MD, Sousa, Amanda, MD, PhD, Moreira, Adriana C., MD, Costa, Ricardo A., MD, Cano, Manuel, MD, Maldonado, Galo, MD, Campos, Cantídio, BS, Carballo, Mariana, BS, Pavanello, Ricardo, MD, Sousa, J. Eduardo, MD

“…Objectives Our aim was to access the incidence of late major adverse cardiac events (MACE) and stent thrombosis (ST) in nonselected, complex patients followed…”
Get full text

One-year results of the INSPIRE trial with the novel MGuard stent: Serial analysis with QCA and IVUS by Costa Jr, J. Ribamar, Abizaid, Alexandre, Feres, Fausto, Costa, Ricardo, Staico, Rodolfo, Siqueira, Dimytri, Centemero, Marinella, Tanajura, Luiz Fernando, Sousa, Amanda, Sousa, J. Eduardo

“…Background: The newly developed balloon‐expandable Mguard stent system, a combination of an ultra‐thin polymer mesh sleeve attached to the external surface of…”
Get full text

Preliminary results of the INSPIRE trial with the novel MGuard™ stent system containing a protection net to prevent distal embolization by Maia, Felipe, Ribamar Costa Jr, J., Abizaid, Alexandre, Feres, Fausto, Costa, Ricardo, Staico, Rodolfo, Siqueira, Dimytri, Esteves, Vinicius, Sousa, Amanda, Eduardo Sousa, J.

“…Objective: To assess the efficacy of the MGuardTM stent combining a polymer‐mesh sleeve attached to the external surface of a bare‐metal stent in preventing…”
Get full text

The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry by Abizaid, Alexandre, Costa, Jr, J Ribamar, Banning, Adrian, Bartorelli, Antonio L, Dzavik, Vladimir, Ellis, Stephen, Gao, Runlin, Holmes, Jr, David R, Jeong, Muyng Ho, Legrand, Victor, Neumann, Franz-Josef, Nyakern, Maria, Orlick, Amy, Spaulding, Christian, Worthley, Stephen, Urban, Philip M

“…This study sought to compare the 1-year safety and efficacy of Cypher Select or Cypher Select Plus (Cordis Corporation, Bridgewater, New Jersey)…”
Get full text

Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system by Costa, Jr, J Ribamar, Abizaid, Alexandre, Costa, Ricardo, Feres, Fausto, Tanajura, Luís Fernando, Abizaid, Andréa, Mattos, Luiz Alberto, Staico, Rodolfo, Siqueira, Dimytri, Sousa, Amanda G M R, Bonan, Raoul, Sousa, J Eduardo

“…We sought to investigate the performance and efficacy of the third-generation polymer-free Vestasync-eluting stent (VES). Recent concerns regarding the…”
Get full text

Initial experience of two national centers in transcatheter aortic prosthesis implantation by Lluberas, Sebastián, Abizaid, Alexandre, Siqueira, Dimytri, Ramos, Auristela, Costa, Jr, J Ribamar, Arrais, Magaly, Kambara, Antônio, Bihan, David Le, Sousa, Amanda, Sousa, J Eduardo

“…Transcatheter aortic valve implantation is an effective alternative to surgical treatment of severe aortic stenosis in patients who are inoperable or at high…”
Get full text

Experiência Inicial de Dois Centros Nacionais no Implante de Prótese Aórtica Transcateter by Lluberas, Sebastián, Abizaid, Alexandre, Siqueira, Dimytri, Ramos, Auristela, Costa Jr, J. Ribamar, Arrais, Magaly, Kambara, Antônio, Bihan, David Le, Sousa, Amanda, Sousa, J. Eduardo

“…Fundamento: O implante de prótese aórtica transcateter é uma alternativa efetiva para o tratamento cirúrgico para a correção de estenose aórtica grave em…”
Get full text

New Drug-Eluting Stents: An Overview on Biodegradable and Polymer-Free Next-Generation Stent Systems by Abizaid, Alexandre, Costa, J Ribamar

Get full text

Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents: The OPTIMIZE Randomized Trial by Feres, Fausto, Costa, Ricardo A, Abizaid, Alexandre, Leon, Martin B, Marin-Neto, J. Antônio, Botelho, Roberto V, King, Spencer B, Negoita, Manuela, Liu, Minglei, de Paula, J. Eduardo T, Mangione, José A, Meireles, George X, Castello, Hélio J, Nicolela, Eduardo L, Perin, Marco A, Devito, Fernando S, Labrunie, André, Salvadori, Décio, Gusmão, Marcos, Staico, Rodolfo, Costa, J. Ribamar, de Castro, Juliana P, Abizaid, Andrea S, Bhatt, Deepak L

“…IMPORTANCE The current recommendation is for at least 12 months of dual antiplatelet therapy after implantation of a drug-eluting stent. However, the optimal…”
Get full text